Found 1211 matching trials
biomArkers to differeNtiate bacTerial From vIral iNfEctions NA ANTOINE is a prospective trial which aims to assess diagnostic performance ...
Show More Location
Hospices Civils de Lyon
Learn More & Join Trial
Developing Biomarkers of Dietary Intake PHASE1 Background:
\- Researchers who study health and nutrition are interested i...
Show More Learn More & Join Trial
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer NA RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Imaging Biomarkers of Pancreatic Function and Disease PHASE4 This study seeks to understand the performance of MRI to characterize pancr...
Show More Status
Enrolling By Invitation
Location
Cincinnati Children's Hospital Medical Center
Learn More & Join Trial
Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer PHASE2 This phase II trial is studying how well cediranib maleate works in treatin...
Show More Location
Massachusetts General Hospital Cancer Center
Learn More & Join Trial
Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2 PHASE1 RATIONALE: Lapatinib may stop the growth of tumor cells by blocking some of...
Show More Location
UCSF Helen Diller Family Comprehensive Cancer Center
Learn More & Join Trial
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck PHASE2 RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Show More Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Learn More & Join Trial
Investigation of Cisplatin-Related Kidney Toxicity N/A The purpose of this study is to identify novel biomarkers of kidney injury ...
Show More Location
University of Chicago
Learn More & Join Trial
ABT-510 in Treating Patients With Metastatic Melanoma PHASE2 RATIONALE: ABT-510 may stop the growth of melanoma by blocking blood flow t...
Show More Location
Multiple Locations
Learn More & Join Trial
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA PHASE2 This phase II trial examines the use of blood-based biomarkers is to help i...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial